In the first half of the year，339, 000 cases of invention patent were authorized in China. As of the end of June 2021, there were 3, 324,000 cases of valid invention patent, a year-on-year increase of 23.0%, and 33, 300 cases of accepted PCT international patent application, a year-on-year increase of 12.6 %.

In the first half of the year, there were 1, 327, 000 cases of utility model patent granted and 393, 000 cases of industrial design patent granted, with the number of 28, 400 cases of patent reevaluation closed and 4, 300 cases of announcement of invalidation closed.

In the first half of the year, there were 3,724,000 cases of trademarks registration in China. As of the end of June 2021, the number of valid registered trademarks was 33,548,000, a year-on-year increase of 22.4%. And 2,954 applications for the Madrid International Trademark Registration from the applicants were received.

In the first half of the year, the CNIPA examined 82,000 cases of trademark opposition and tired 188,000 cases of trademark review.

In the first half of the year, the CNIPA identified 87 products protected by geographical indications, examined and approved 254 cases of registration of geographical indications as collective trademarks and certification trademarks, with 3355 market entities for the use of special geographical indication. As of June 2021, an accumulative total of 2,478 products protected by geographical indications have been identified, an accumulative total of 6,339 geographical indications registered as collective trademarks and certification trademarks have been examined and approved, and 12,789 market entities using geographical indications have been examined and approved.

In the first half of the year, 7,629 IC layout designs were registered and issued certificates, which continued maintaining rapid growth.

In the first half of the year, there were 13,800 administrative adjudication cases involving patent infringement disputes nationwide. The patent and trademark pledge financing throughout the country amounted to 107.4 billion yuan, a year-on-year increase of 25.9%; the number of pledge projects was 6,195, a year-on-year increase of 32.4%.

As of the end of June, the average examination period for invention patents in our country has been reduced to 19.4 months, the examination period for high-value patents has been reduced to 13.4 months, and the average examination period for trademark registration has stabilized within 4 months.

In the first half of the year, the number of granted invention patents of foreign applicants in China was 54,000, a year-on-year increase of 30.0%; the trademark registration of foreign applicants in China amounted to 90,000, a year-on-year increase of 7.5%, wherein the invention patent authorization and trademark registration of the US applicants in China respectively increased by 35.0% and 8.9% year-on-year.

On July 4, the National Medical Products Administration and the CNIPA jointly issued the Implementation Measures for the Early Resolution Mechanism of Drug Patent Disputes (Trial). On July 5, the CNIPA issued the Administrative Adjudication Measures for the Early Resolution Mechanism of Drug Patent Disputes, and the Supreme People's Court also issued related judicial interpretations.

Based on clarifying the central authority for handling major patent infringement disputes in the newly revised Patent Law, the CNIPA issued the Administrative Adjudication Measures for Major Patent Infringement Disputes on May 31 this year.

From CNIPA

July 14th, 2021